周二夜盘，医疗保健公司Clover Health（CLOV）股价大幅下跌12.28%，引发市场关注。这一跌幅主要源于公司发布的第二季度财报未能完全满足投资者预期。
根据公司公布的财报，Clover Health第二季度调整后每股亏损2美分，虽然好于分析师预期的亏损3美分，但仍低于去年同期的每股收益1美分。公司季度营收同比增长34.1%，达到4.7762亿美元，超过分析师预期的4.683亿美元。尽管营收增长强劲，公司仍报告季度亏损1,058万美元。
虽然Clover Health的业绩在某些方面超出预期，但投资者似乎对公司持续亏损感到失望。分析师对该公司的平均评级为"持有"，12个月目标价中位数为4.50美元。然而，此次大幅下跌表明市场对公司短期内扭亏为盈的能力产生了怀疑。投资者将密切关注公司未来的盈利能力和增长前景。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.